Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas

shinji itoh, Kazutoyo Morita, Shigeru Ueda, Keishi Sugimachi, Yo Ichi Yamashita, Tomonobu Gion, Kengo Fukuzawa, Kenzo Wakasugi, Akinobu Taketomi, Yoshihiko Maehara

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Recently, local ablation therapy has been widely used for treatment of small hepatocellular carcinoma (HCC). The present study assessed the outcome of hepatic resection combined with intraoperative local ablation therapy in patients with multinodular HCCs. Methods: Forty-one patients with initial and multinodular HCCs underwent hepatic resection combined with intraoperative local ablation therapy. The mean maximum diameter of all tumors was 3.8 cm (range 2.1-16.0 cm), and the mean number of nodules was 3.2 (range 2-11). We evaluated the survival rates and assessed the prognostic factors associated with overall survival rates using Cox proportional hazard models. Results: Intraoperative local ablation therapy was completed in all patients with no evidence of residual viable tumor on the first postoperative computed tomography (CT) scan. The 3-, 5- and 7-year overall survival rates were 84.3%, 61.2%, and 61.2%, respectively. Patients with preoperative des-gamma carboxyprothrombin (DCP) level >300 mAU/ml showed significantly worse overall survival than those with DCP level >300 mAU/ml (P < 0.01). Conclusions: Hepatic resection combined with intraoperative local ablation therapy is effective for multinodular HCCs. DCP >300 mAU/ml was a significant prognostic factor of long-term overall survival.

Original languageEnglish
Pages (from-to)3299-3307
Number of pages9
JournalAnnals of Surgical Oncology
Volume16
Issue number12
DOIs
Publication statusPublished - Dec 1 2009

Fingerprint

Hepatocellular Carcinoma
Liver
Survival Rate
Therapeutics
Survival
Residual Neoplasm
Proportional Hazards Models
Tomography
Outcome Assessment (Health Care)
Neoplasms
acarboxyprothrombin

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. / itoh, shinji; Morita, Kazutoyo; Ueda, Shigeru; Sugimachi, Keishi; Yamashita, Yo Ichi; Gion, Tomonobu; Fukuzawa, Kengo; Wakasugi, Kenzo; Taketomi, Akinobu; Maehara, Yoshihiko.

In: Annals of Surgical Oncology, Vol. 16, No. 12, 01.12.2009, p. 3299-3307.

Research output: Contribution to journalArticle

itoh, S, Morita, K, Ueda, S, Sugimachi, K, Yamashita, YI, Gion, T, Fukuzawa, K, Wakasugi, K, Taketomi, A & Maehara, Y 2009, 'Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas', Annals of Surgical Oncology, vol. 16, no. 12, pp. 3299-3307. https://doi.org/10.1245/s10434-009-0721-0
itoh, shinji ; Morita, Kazutoyo ; Ueda, Shigeru ; Sugimachi, Keishi ; Yamashita, Yo Ichi ; Gion, Tomonobu ; Fukuzawa, Kengo ; Wakasugi, Kenzo ; Taketomi, Akinobu ; Maehara, Yoshihiko. / Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. In: Annals of Surgical Oncology. 2009 ; Vol. 16, No. 12. pp. 3299-3307.
@article{1b87a4eb78ba4b349ff0bc23fd3b51e5,
title = "Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas",
abstract = "Background: Recently, local ablation therapy has been widely used for treatment of small hepatocellular carcinoma (HCC). The present study assessed the outcome of hepatic resection combined with intraoperative local ablation therapy in patients with multinodular HCCs. Methods: Forty-one patients with initial and multinodular HCCs underwent hepatic resection combined with intraoperative local ablation therapy. The mean maximum diameter of all tumors was 3.8 cm (range 2.1-16.0 cm), and the mean number of nodules was 3.2 (range 2-11). We evaluated the survival rates and assessed the prognostic factors associated with overall survival rates using Cox proportional hazard models. Results: Intraoperative local ablation therapy was completed in all patients with no evidence of residual viable tumor on the first postoperative computed tomography (CT) scan. The 3-, 5- and 7-year overall survival rates were 84.3{\%}, 61.2{\%}, and 61.2{\%}, respectively. Patients with preoperative des-gamma carboxyprothrombin (DCP) level >300 mAU/ml showed significantly worse overall survival than those with DCP level >300 mAU/ml (P < 0.01). Conclusions: Hepatic resection combined with intraoperative local ablation therapy is effective for multinodular HCCs. DCP >300 mAU/ml was a significant prognostic factor of long-term overall survival.",
author = "shinji itoh and Kazutoyo Morita and Shigeru Ueda and Keishi Sugimachi and Yamashita, {Yo Ichi} and Tomonobu Gion and Kengo Fukuzawa and Kenzo Wakasugi and Akinobu Taketomi and Yoshihiko Maehara",
year = "2009",
month = "12",
day = "1",
doi = "10.1245/s10434-009-0721-0",
language = "English",
volume = "16",
pages = "3299--3307",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas

AU - itoh, shinji

AU - Morita, Kazutoyo

AU - Ueda, Shigeru

AU - Sugimachi, Keishi

AU - Yamashita, Yo Ichi

AU - Gion, Tomonobu

AU - Fukuzawa, Kengo

AU - Wakasugi, Kenzo

AU - Taketomi, Akinobu

AU - Maehara, Yoshihiko

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Background: Recently, local ablation therapy has been widely used for treatment of small hepatocellular carcinoma (HCC). The present study assessed the outcome of hepatic resection combined with intraoperative local ablation therapy in patients with multinodular HCCs. Methods: Forty-one patients with initial and multinodular HCCs underwent hepatic resection combined with intraoperative local ablation therapy. The mean maximum diameter of all tumors was 3.8 cm (range 2.1-16.0 cm), and the mean number of nodules was 3.2 (range 2-11). We evaluated the survival rates and assessed the prognostic factors associated with overall survival rates using Cox proportional hazard models. Results: Intraoperative local ablation therapy was completed in all patients with no evidence of residual viable tumor on the first postoperative computed tomography (CT) scan. The 3-, 5- and 7-year overall survival rates were 84.3%, 61.2%, and 61.2%, respectively. Patients with preoperative des-gamma carboxyprothrombin (DCP) level >300 mAU/ml showed significantly worse overall survival than those with DCP level >300 mAU/ml (P < 0.01). Conclusions: Hepatic resection combined with intraoperative local ablation therapy is effective for multinodular HCCs. DCP >300 mAU/ml was a significant prognostic factor of long-term overall survival.

AB - Background: Recently, local ablation therapy has been widely used for treatment of small hepatocellular carcinoma (HCC). The present study assessed the outcome of hepatic resection combined with intraoperative local ablation therapy in patients with multinodular HCCs. Methods: Forty-one patients with initial and multinodular HCCs underwent hepatic resection combined with intraoperative local ablation therapy. The mean maximum diameter of all tumors was 3.8 cm (range 2.1-16.0 cm), and the mean number of nodules was 3.2 (range 2-11). We evaluated the survival rates and assessed the prognostic factors associated with overall survival rates using Cox proportional hazard models. Results: Intraoperative local ablation therapy was completed in all patients with no evidence of residual viable tumor on the first postoperative computed tomography (CT) scan. The 3-, 5- and 7-year overall survival rates were 84.3%, 61.2%, and 61.2%, respectively. Patients with preoperative des-gamma carboxyprothrombin (DCP) level >300 mAU/ml showed significantly worse overall survival than those with DCP level >300 mAU/ml (P < 0.01). Conclusions: Hepatic resection combined with intraoperative local ablation therapy is effective for multinodular HCCs. DCP >300 mAU/ml was a significant prognostic factor of long-term overall survival.

UR - http://www.scopus.com/inward/record.url?scp=71549126218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71549126218&partnerID=8YFLogxK

U2 - 10.1245/s10434-009-0721-0

DO - 10.1245/s10434-009-0721-0

M3 - Article

VL - 16

SP - 3299

EP - 3307

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 12

ER -